| | | | | S-ii | | | |
| | | | | S-iii | | | |
| | | | | S-iii | | | |
| | | | | S-iv | | | |
| | | | | S-1 | | | |
| | | | | S-6 | | | |
| | | | | S-13 | | | |
| | | | | S-14 | | | |
| | | | | S-15 | | | |
| | | | | S-30 | | | |
| | | | | S-34 | | | |
| | | | | S-40 | | | |
| | | | | S-43 | | | |
| | | | | S-46 | | | |
| | | | | S-46 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 17 | | | |
| | | | | 27 | | | |
| | | | | 32 | | | |
| | | | | 40 | | | |
| | | | | 42 | | | |
| | | | | 43 | | | |
| | | | | 44 | | | |
| | | | | 46 | | | |
| | | | | 48 | | | |
| | | | | 50 | | | |
| | | | | 50 | | |
| | |
September 30, 2021
|
| |||||||||
| | |
Actual
|
| |
As adjusted
|
| ||||||
| | |
(unaudited) (dollars in thousands,
except per share data) |
| |||||||||
Long term debt: | | | | | | | | | | | | | |
Deposits
|
| | | $ | 16,622,160 | | | | | $ | 16,622,160 | | |
Securities sold under agreements to repurchase
|
| | | | 95,181 | | | | | | 95,181 | | |
Long-term borrowings(1)
|
| | | | 140,584 | | | | | | 140,584 | | |
2026 subordinated notes(2)
|
| | | | 150,000 | | | | | | — | | |
Subordinated notes offered hereby
|
| | | | — | | | | | | | | |
Other liabilities
|
| | | | 233,293 | | | | | | 233,293 | | |
Total liabilities
|
| | | | 17,241,218 | | | | | | | | |
Stockholders’ equity: | | | | | | | | | | | | | |
Preferred stock; $10.00 par value, 500,000; 17,250 issued and outstanding, shares at September 30, 2021
|
| | | $ | 173 | | | | | $ | 173 | | |
Common stock; $1.33 par value, shares authorized 200,000,000; 75,645,031
issued and outstanding, shares at September 30, 2021 |
| | | | 100,062 | | | | | | 100,062 | | |
Additional paid-in capital
|
| | | | 1,804,617 | | | | | | 1,804,617 | | |
Retained earnings
|
| | | | 760,164 | | | | | | 760,164 | | |
Accumulated other comprehensive income
|
| | | | 29,423 | | | | | | 29,423 | | |
Total stockholders’ equity
|
| | | | 2,694,439 | | | | | | 2,694,439 | | |
Total liabilities and stockholders’ equity
|
| | | $ | 19,935,657 | | | | | $ | | | |
Capital Ratios | | | | | | | | | | | | | |
Common equity tier 1 capital to risk-weighted assets
|
| | | | 10.37% | | | | | | 10.37% | | |
Tier 1 capital to risk-weighted assets
|
| | | | 11.49% | | | | | | 11.49% | | |
Total capital to risk-weighted assets
|
| | | | 13.78% | | | | | | % | | |
Tier 1 leverage to average assets
|
| | | | 8.97% | | | | | | % | | |
Initial Purchasers
|
| |
Principal Amount
|
| |||
Keefe, Bruyette & Woods, Inc.
|
| | | $ | | | |
Piper Sandler & Co.
|
| | | $ | | | |
Goldman Sachs & Co. LLC
|
| | | $ | | | |
Raymond James & Associates, Inc.
|
| | | $ | | | |
Total
|
| | | $ | | | |
|
Per Note
|
| | | | % | | |
|
Total
|
| | | $ | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 4 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 11 | | | |
| | | | 17 | | | |
| | | | 27 | | | |
| | | | 32 | | | |
| | | | 40 | | | |
| | | | 42 | | | |
| | | | 43 | | | |
| | | | 44 | | | |
| | | | 46 | | | |
| | | | 48 | | | |
| | | | 50 | | | |
| | | | 50 | | |